Barclays PLC Optimize Rx Corp Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Optimize Rx Corp stock. As of the latest transaction made, Barclays PLC holds 26,934 shares of OPRX stock, worth $132,245. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,934

Previous 26,934 -0.0%

Holding current value

$132,245

Previous $208,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$7.2 - $11.23 $151,632 - $236,503	21,060 Added 358.53%	26,934 $208,000
Q2 2024 Aug 14, 2024	SELL	$8.8 - $13.17 $45,953 - $68,773	-5,222 Reduced 47.06%	5,874 $59,000
Q1 2024 May 15, 2024	SELL	$11.47 - $16.17 $127,018 - $179,066	-11,074 Reduced 49.95%	11,096 $135,000
Q4 2023 Feb 15, 2024	BUY	$7.06 - $14.49 $136,660 - $280,482	19,357 Added 688.13%	22,170 $317,000
Q3 2023 Nov 07, 2023	SELL	$7.43 - $14.96 $3,655 - $7,360	-492 Reduced 14.89%	2,813 $22,000
Q2 2023 Aug 03, 2023	SELL	$11.63 - $15.63 $59,743 - $80,291	-5,137 Reduced 60.85%	3,305 $47,000
Q1 2023 May 04, 2023	BUY	$12.54 - $19.38 $3,323 - $5,135	265 Added 3.24%	8,442 $124,000
Q4 2022 Feb 13, 2023	BUY	$13.77 - $22.04 $44,463 - $71,167	3,229 Added 65.26%	8,177 $137,000
Q3 2022 Nov 03, 2022	SELL	$13.74 - $30.13 $9,343 - $20,488	-680 Reduced 12.08%	4,948 $73,000
Q2 2022 Aug 12, 2022	SELL	$21.94 - $40.49 $198,337 - $366,029	-9,040 Reduced 61.63%	5,628 $154,000
Q1 2022 May 16, 2022	SELL	$35.27 - $62.91 $275,599 - $491,578	-7,814 Reduced 34.76%	14,668 $553,000
Q4 2021 Feb 14, 2022	SELL	$53.57 - $98.0 $343,222 - $627,886	-6,407 Reduced 22.18%	22,482 $1.4 Million
Q3 2021 Nov 09, 2021	BUY	$50.93 - $85.55 $1.32 Million - $2.21 Million	25,845 Added 849.05%	28,889 $2.47 Million
Q2 2021 Aug 13, 2021	SELL	$42.76 - $63.33 $453,213 - $671,234	-10,599 Reduced 77.69%	3,044 $188,000
Q1 2021 May 13, 2021	BUY	$33.36 - $62.2 $295,169 - $550,345	8,848 Added 184.53%	13,643 $665,000
Q4 2020 Feb 11, 2021	SELL	$19.04 - $33.1 $35,566 - $61,830	-1,868 Reduced 28.04%	4,795 $149,000
Q3 2020 Nov 12, 2020	SELL	$12.99 - $21.78 $16,861 - $28,270	-1,298 Reduced 16.3%	6,663 $139,000
Q2 2020 Aug 12, 2020	BUY	$8.34 - $13.69 $28,022 - $45,998	3,360 Added 73.03%	7,961 $103,000
Q1 2020 May 13, 2020	SELL	$6.71 - $11.4 $85,170 - $144,700	-12,693 Reduced 73.4%	4,601 $42,000
Q4 2019 Feb 10, 2020	BUY	$8.8 - $14.08 $60,640 - $97,025	6,891 Added 66.24%	17,294 $178,000
Q3 2019 Nov 14, 2019	BUY	$13.6 - $16.96 $36,420 - $45,418	2,678 Added 34.67%	10,403 $151,000
Q2 2019 Aug 14, 2019	SELL	$10.43 - $16.62 $94,005 - $149,796	-9,013 Reduced 53.85%	7,725 $125,000
Q1 2019 May 15, 2019	BUY	$10.74 - $15.59 $179,766 - $260,945	16,738 New	16,738 $213,000

Others Institutions Holding OPRX

# of Institutions

Shares Held

12.2M

Call Options Held

800

Put Options Held

18.1K

View Full List

About OptimizeRx Corp

Ticker OPRX
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 18,023,100
Market Cap $88.5M
Description
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...

More about OPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account